These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9632068

  • 1. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y, Ogaki M, Abe K, Takeuchi K, Ando S, Tokano Y, Kobayashi S, Sekigawa I, Tsuda H, Hashimoto H.
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [Abstract] [Full Text] [Related]

  • 2. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 3. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [Abstract] [Full Text] [Related]

  • 4. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Dec; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 5. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O.
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [Abstract] [Full Text] [Related]

  • 6. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH, Shen Q, Zhao DB, Cai Q, Han XH.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):318-23. PubMed ID: 15854508
    [Abstract] [Full Text] [Related]

  • 7. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 02; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 8. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 02; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 9. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK, Lit LC, Tam LS, Li EK, Lam CW.
    Rheumatology (Oxford); 2005 Aug 02; 44(8):989-94. PubMed ID: 15870153
    [Abstract] [Full Text] [Related]

  • 10. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec 02; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 11. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
    Wenzel J, Henze S, Brähler S, Bieber T, Tüting T.
    Exp Dermatol; 2005 Jun 02; 14(6):454-9. PubMed ID: 15885081
    [Abstract] [Full Text] [Related]

  • 12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA.
    Br J Dermatol; 2004 Apr 02; 150(4):693-700. PubMed ID: 15099365
    [Abstract] [Full Text] [Related]

  • 13. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
    Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS.
    Arthritis Rheum; 2001 Apr 02; 44(4):856-65. PubMed ID: 11315925
    [Abstract] [Full Text] [Related]

  • 14. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May 02; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE.
    Ann Rheum Dis; 2008 Jul 02; 67(7):1037-40. PubMed ID: 18199598
    [Abstract] [Full Text] [Related]

  • 16. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A, Morimoto S, Nakiri Y, Suzuki J, Kaneko H, Tokano Y, Tsuda H, Takasaki Y, Hashimoto H.
    Rheumatology (Oxford); 2006 Dec 02; 45(12):1477-84. PubMed ID: 16638798
    [Abstract] [Full Text] [Related]

  • 17. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D, Yasuda J, Yoshida K, Yoneda A, Yasuda C, Kingetsu I, Toyokawa Y, Yokoyama T, Saito S, Yamada A.
    J Rheumatol; 2006 Jun 02; 33(6):1102-7. PubMed ID: 16755657
    [Abstract] [Full Text] [Related]

  • 18. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S, Soltész P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S.
    Autoimmunity; 2007 Nov 02; 40(7):521-8. PubMed ID: 17966042
    [Abstract] [Full Text] [Related]

  • 19. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O.
    Scand J Immunol; 2007 Nov 02; 66(5):584-90. PubMed ID: 17868260
    [Abstract] [Full Text] [Related]

  • 20. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT.
    Arthritis Rheum; 2009 Jan 02; 60(1):207-18. PubMed ID: 19116915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.